Skip to main content
SpringerLink
Log in

Valproate in the treatment of epilepsies in children

  • Chapter
Valproate

Part of the book series: Milestones in Drug Therapy ((MDT))

  • 363 Accesses

Abstract

The treatment of epilepsy with valproate in childhood must take into account the wide range of clinical presentations of epilepsy, including specific responses to the drug, and pharmacological and toxicological particularities in this age range.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aicardi J, Praud E, Bancaud J, Mises J, Chevrie JJ (1970) Epilepsies cliniquement primitives et tumeurs cérébrales chez l’enfant. Arch Fr Pediatr 27: 1041–1055

    PubMed  CAS  Google Scholar 

  2. Beck-Mannagetta G, Anderson E, Doose H, Janz D (eds) (1989) Genetics of the epilepsies. Springer-Verlag, Berlin

    Google Scholar 

  3. Dulac O (1995) Epileptic syndromes in infancy and childhood: recent advances. Epilepsia 36: S51–S57

    Article  PubMed  Google Scholar 

  4. Gastaut H, Vigouroux M, Trevisan C et al (1957) Le syndrome hémiconvulsions-hémiplégie-épilepsie (syndrome H.H.E.). Rev Neurol 97: 37–52

    PubMed  CAS  Google Scholar 

  5. Perucca E, Grant L, Avanzini G, Dulac O (1998) Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39: 5–17

    Article  PubMed  CAS  Google Scholar 

  6. Klotz U (1982) Bioavailability of a slow release preparation of valproic acid under steady state conditions. Int J Pharmacol ther Toxicol 20: 24–26

    CAS  Google Scholar 

  7. Jeavons PM (1984) Non-dose-related side effects of valproate. Epilepsia 25 (suppl 1): S50–S55.

    Article  PubMed  Google Scholar 

  8. Dinesen H, Gram L, Anderson T, Dam M (1984). Weight gain during treatment with valproate. Acta Neurolog Scand; 70: 65–69

    Article  CAS  Google Scholar 

  9. Scheffner D, König S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S (1988) Fatal liver failure in 16 children with valproate therapy. Epilepsia 29: 530–542

    Article  PubMed  CAS  Google Scholar 

  10. Hellström-Westas L, Blennow G, Lindroth M, Rosén I, Svenningson N (1995) Low risk of seizure recurrence after early withdraw of antiepileptic treatment in the neonatal period. Arch Dis Child 72 (suppl 2): F97–F101.

    Google Scholar 

  11. Sussman NM, McLain LW. (1979). A direct hepatotoxic effect of valproic acid. JAMA 242: 1173–1174

    Article  PubMed  CAS  Google Scholar 

  12. Collettir B, Trainer TD, Karwisz BR. (1986). Reversible valproate fulminant hepatic failure. J Pediatr Gastroenterol Nutr 5: 990–994

    Article  Google Scholar 

  13. Asconapé JJ, Penry JK, Dreifuss FE et al. (1992). Valproate-associated pancreatitis. Epilepsia 34: 117–123

    Google Scholar 

  14. Pisani F, Narbona MC, Trunfio C, Fazio A, La Rosa G, Oteri G, Di Perri R (1984) Valproic acid-ethosuximide interaction: a pharmacokinetic study. Epilepsia 25: 229–233

    Article  PubMed  CAS  Google Scholar 

  15. Ramsay RE, Mc Manus D, Guterman A, Briggle T, Vasques D, et al (1990) Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. The Drug Monit 12: 235–241

    Article  CAS  Google Scholar 

  16. Jeavons PM, Clark JE, Maheswari MC (1977) Treatment of generalised epilepsies of childhood with sodium valproate (epilim). Dev Med Child Neurol 19: 9–25

    Article  PubMed  CAS  Google Scholar 

  17. Lai ML, Huang JD (1993) Dual effect of valproic acid on the pharmacokinetic of phenytoin Biopharm Drug Dispos 14: 365–370

    Article  PubMed  CAS  Google Scholar 

  18. Dulac O (1998). Convulsions et epilepsies du nouveau-né et du nourrisson In: Ponsot G, Arthuis M, Pinsard N, Dulac O, Mancini J (eds): Neurologie pediatrique,deuxieme édition. Flammarion, Paris, 367–406

    Google Scholar 

  19. Vigevano F, Fusco L, Di Capua M et al (1994) Benign infantile familial convulsions: Clinical and genetics aspects. Pediatric Neurology 11: 94

    Article  Google Scholar 

  20. Malafosse A, Beck C, Bellet H, Di Capua M et al (1994) Benign infantile familial convulsions are not an allelic form of the benign familial neonatal convulsions gene. Ann Neurol 35: 479–482

    Article  PubMed  CAS  Google Scholar 

  21. Leppert M, Anderson VE, Quateblaum T, Stauffer D et al (1989) Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337 (6208): 647–648

    Article  PubMed  CAS  Google Scholar 

  22. Othahara S, Ohtsuka Y, Yamatogi Y (1987) The early infantile epileptic encephalopaty with suppression-bursts: Developmental aspects. Brain Dev 9: 371–376

    Article  Google Scholar 

  23. Schlumberger E, Dulac O, Pluin P (1992) Syndrome (s) d’epilepsie néonatale avec “suppression-burst”: approche nosologique. In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P (eds): Epileptic syndromes in infancy, childhood and adolescence. John Libbey, London-Paris: 35–42

    Google Scholar 

  24. Nelson K, Ellenberg J (eds) (1981) Febrile seizures. Raven Press, New York.

    Google Scholar 

  25. Dalla Bernardina B, Colamaria V, Capovilla G, Bondavalli S, Bureau M (1982) Epilepsie myoclonique grave de la première année. Rev Electroencephalogr Neurophysiol Clin 12: 21–25

    Article  Google Scholar 

  26. Aicardi J, Chevrie JJ (1973) The significance of electroencephalographic paroxysms in children less than three years of age. Epilepsia 14: 47–55

    Article  PubMed  CAS  Google Scholar 

  27. Martin-Fernandez JJ, Molto-Jorda JM, Villaverde R, Salmeron P, Prieto-Munoz I, Fernandez-Barreiro A. (1996) Risk factors in recurrent febrile seizures. Rev Neurol 24 (136): 1520–1524

    PubMed  CAS  Google Scholar 

  28. Knudsen FU (1996) Febrile seizures- Treatment and outcome. Brain Dev 18: 438–449

    Article  PubMed  CAS  Google Scholar 

  29. Daugbjerg P, Brems M, Mai J, Ankerhus J, Knudsen FU (1990) Intermittent prophilaxis in febrile convulsions: diazepam or valproic acid ? Acta Neurol Scand 82: 17–20

    Article  PubMed  CAS  Google Scholar 

  30. Camfield CS, Chaplin S, Doyle AB, Shapiro SH, Cunning C, Camfield PR (1979). Side effects of phenobarbital in toddlers: Behavioral and cognitive aspects. J Pediatr 95: 361–365

    Article  PubMed  CAS  Google Scholar 

  31. Byrne JM, Camfield PR, Clark-Touesnard M, Hondas BJ (1987) Effects of phenobarbital on early intellectual and behavioral development: A concordance twin case study. J ClinExp Neuropsychol 9: 393–398

    Article  PubMed  CAS  Google Scholar 

  32. Dravet Ch, Bureau M, Guerrini R, Giraud N, Roger J (1992) Severe myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P (eds): Epileptic syndromes in infancy, childhood and adolescence. John Libbey, London & Paris, 75–88

    Google Scholar 

  33. Yakoub M, Dulac O, Jambaque I et al (1992) Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 14: 299–303

    Article  PubMed  CAS  Google Scholar 

  34. Chiron C, Dulac O (1994) Les différents syndromes épileptiques chez le nourrisson. In: Pons G, Dulac O, Ben-Ari Y (eds): Les médicaments antiépileptiques chez l’enfant. Springer-Verlag, Paris, 47–55

    Google Scholar 

  35. Chapman AG, Horton RW, Meldrum BS (1979) Anticonvulsant Action of a 1,5-benzodiazepine, clobazam, in epilepsy. Epilepsia 19: 293–299

    Article  Google Scholar 

  36. Schmidt D, Rohde M, Wolf P, Roeder-Wanner U (1986) Tolerance to the antiepileptic effect of clobazam In• Koella WP, Frey HH, Froscher W, Meinardi H, (eds): Tolerance to beneficial and adverse effects of antiepileptic drug. Raven Press, New York, 109–115

    Google Scholar 

  37. Watanabe K (1996) Benign partial epilepsies. In: Wallace S (ed): Epilepsy in children.

    Google Scholar 

  38. Degen R, Dreifuss FE (1992) Localised and generalised epilepsies of early childhood. Epilepsy Res. Suppl 6

    Google Scholar 

  39. Verity CM, Hosking G, Easter DJ (1995) A multicentre trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 37 (2): 97–108

    Article  PubMed  CAS  Google Scholar 

  40. Chaigne D, Dulac O (1989) Carbamazepine versus valproate in partial epilepsies of childhood. Advances in epileptology 17: 198–200

    Google Scholar 

  41. Bureau M, Dravet Ch, Genton P, Roger J, Weber M (eds) (1993) Les épilepsies de 1 ‘enfant. Doc médicale Labaz, Paris

    Google Scholar 

  42. Berkovic S, Scheffer I (1997) Epilepsies with single gene inheritance. Brain Dev 19 (1): 13–18.

    Article  PubMed  CAS  Google Scholar 

  43. Dulac O (1998) Epilepsies et convulsions de l’enfant. Encyclop Med Cirurg. Elsevier: Paris. Pédiatrie 4–091-A-10, 26 p

    Google Scholar 

  44. Vigevano F, Fusco L, Cusmai R, Claps D, Ricci S, Milani L (1993) The idiopatic form of West syndrome. Epilepsia 34: 743–747

    Article  PubMed  CAS  Google Scholar 

  45. Dulac O, Plovin P, Jambaqué I (1993) Predicting favorable outcome in idiopathic West syndrome. Epilepsia 34: 747–756

    Article  PubMed  CAS  Google Scholar 

  46. Simon D, Penry JK (1975) Sodium de-N-propylacetate in the treatment of epilepsy. Epilepsia 16: 549–573

    Article  PubMed  CAS  Google Scholar 

  47. Bachman D (1982) Use of valproic acid in treatment of infantile spasm. Arch Neurol 39: 49–52

    Article  PubMed  CAS  Google Scholar 

  48. Pavone L, Incorpora G, La Rosa M, Li Volti S, Mollica F (1981) Treatment of infantile-spasm with sodium dipropylacetic acid. Dev Med Child Neurol 23: 454–461

    Article  PubMed  CAS  Google Scholar 

  49. Dulac O, Steru D, Rey E, Perret A, Arthuis M (1986) Sodium valproate monotherapy in childhood epilepsy. Brain Dev 8: 47–52

    Article  PubMed  CAS  Google Scholar 

  50. Siemes H, Short HL, Michael TH, Nau H (1988) Therapy of infantile spasm with valproate: results of a prospective study. Epilepsia 29: 553–560

    Article  PubMed  CAS  Google Scholar 

  51. Dreifuss FE, Santilli N (1986) Valproic acid fatalities: Analysis of US cases. Neurology 36 (suppl 1)

    Google Scholar 

  52. Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac OP (1996) Ramdomized trial comparing vigabatrin and hydrocortisone in infantile spasm due to tuberous sclerosis. Epilepsy Research 26: 389–395

    Article  Google Scholar 

  53. Dulac O, Chugani HT, Dalla Bernardina B (eds) (1994) Infantile spasm and West syndrome. WB Saunders, London

    Google Scholar 

  54. Dalla Bernardina B, Fontana E, Sgro V, Colamaria V, Elia M (1992) Myoclonic epilepsy (myoclonic status) in non-progressive encephalopathies In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P (eds): Epileptic syndromes in infancy, childhood and adolescence. John Libbey, London-Paris, 89–96

    Google Scholar 

  55. Narkewicz MR, Sokol RJ, Beckwith B et al (1991) Liver involvement in Alper’s disease. J Pediatr 119: 260–267

    Article  CAS  Google Scholar 

  56. Zaret BS, Becker RR, Marini MM, Wagle W, Pasarelli C (1982) Sodium valproate induced hyperammonemia without clinical hepatic dysfunction. Neurology 32: 206–208

    Article  PubMed  CAS  Google Scholar 

  57. Dreifuss FE (1995) Valproic acid toxicity, In: RH Levy, RH Mattson, BS Meldrum. (eds): Antiepileptic drugs, fourth edition, Raven Press, New York, 641–648

    Google Scholar 

  58. Loiseau P (1992) Childhood absence epilepsy In: Roger J, Bureau M, Dravet Ch, Perret A, Wolf P (eds): Epileptic syndromes in infancy,childhood and adolescence. John Libbey, London-Paris, 135–150

    Google Scholar 

  59. Olsson I, Campenhausen G (1993) Social adjustement in young adults with absence epilepsies. Epilepsia 34: 846–851

    Article  PubMed  CAS  Google Scholar 

  60. Tassinari C, Bureau M, Thomas P (1992) Epilepsy with myoclonic absences. In: Roger J, Bureau M, Dravet Ch, Perret A, Wolf P (eds): Epileptic syndromes in infancy, childhood and adolescence. John Libbey, London-Paris, 151–161

    Google Scholar 

  61. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac 0 (1994) Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 35: 359–367

    Article  PubMed  CAS  Google Scholar 

  62. Beaumanoir A, Dravet Ch (1992) The Lennox-Gastaut syndrome. In: J Roger, M Bureau, Ch Dravet, A Perret, P Wolf (eds): Epileptic syndromes in infancy,childhood and adolescence. John Libbey, London-Paris, 115–132

    Google Scholar 

  63. O11er LFV, Russi A, O11er Daurella L (1991) Lamotrigine in Lennox-Gastaut syndrome. Epilepsia 32 (suppl 1): 58

    Google Scholar 

  64. Besag FMC, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G (1995) Lamotrigine for the treatment of epilepsy in childhood. The Journal of Pediatrics 6: 991–997

    Article  Google Scholar 

  65. Dulac O, N’Guyen T (1993) The Lennox-Gastaut syndrome. Epilepsia 34 (suppl 7): 7–17

    Article  Google Scholar 

  66. Felbamate study group in Lennox-Gastaut syndrome (1993) Efficacy of felbamate in childhood epileptic encephalopaty (Lennox-Gastaut syndrome). N Engl J Med 328: 29–33

    Article  Google Scholar 

  67. Pellock JM (1997) Overview of lamotrigine and the new antiepileptic drugs: The challenge. J Child Neurol 12 (suppl 1): S48–S52

    Article  PubMed  Google Scholar 

  68. Patry G, Lyagoubi S, Tassinari CA (1971) Subclinical electrical status epilepticus induced by sleep. An electroencephalographic study of six cases. Arch Neurol 24: 242–252

    Article  PubMed  CAS  Google Scholar 

  69. Deonna T, Peter CL, Ziegler A (1989) Adult follow-up of the acquired aphasia epilepsy syndrome in childhood: report of seven cases. Neuropediatrics 20: 132–138

    Article  PubMed  CAS  Google Scholar 

  70. Bednarek N, Motte J, Soufflet C, Plouin P, Dulac O (1998) Evidence of late-onset infantile spasms. Epilepsia 39 (1): 55–60

    Article  PubMed  CAS  Google Scholar 

  71. Dravet Ch, Bureau M, Roger J (1992) Benign myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P (eds): Epileptic syndromes in infancy, childhood and adolescence. John Libbey, London-Paris, 67–74

    Google Scholar 

  72. Guerrini R, Dravet Ch, Gobbi G et al (1994) Idiopathic generalised epilepsy with myoclonus in infancy and childhood. In: A Malafosse, P Genton, E Hirsch et al (eds): Idiopathic generalised epilepsy: clinical, experimental and genetics aspects. John Libbey, London, 267–280

    Google Scholar 

  73. Dulac O, Plouin P, Shewmon A, Contributors to the Royaumont Workshop (1998) Myoclonus and epilepsy in childhood 1996 Royaumont meeting. Epilepsy Research 30: 91–106

    Article  PubMed  CAS  Google Scholar 

  74. Pons G, Dulac O, Ben-Ari Y (eds) (1994) Les médicaments antiépileptiques chez l’enfant. Springer-Verlag, Paris

    Google Scholar 

  75. Panayiotopoulos CP (1993) Interaction of lamotrigine with sodium valproate. Lancet 341: 445

    Article  PubMed  CAS  Google Scholar 

  76. Levy RH, Shen D (1995) Valproic acid: absortion, distribution, and excretion. In: Levy R, Mattson R, Meldrum BS (eds): Antiepileptic drugs, Fourth edition. Raven Press, New York, 605–619

    Google Scholar 

  77. Commission on Antiepileptic Drugs, International League Against Epilepsy. Guidelines for Therapeutic Monitoring on Antiepileptic Drugs. Epilepsia 34 (4): 585–587

    Google Scholar 

  78. Lundberg B, Nergardh A, Boreus L (1982) Plasma concentrations of valproate during maintenance therapy in epileptic children. J Neurol 228: 133–141

    CAS  Google Scholar 

  79. Wallace SJ (1998) Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 29: 147–154

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital de Niños Sor Maria Ludovica, Calle 14 e/65 y 66, CP 1900, La Plata, Argentina

    N. Sarisjulis

  2. Hôpital Saint Vincent de Paul, INSERM U29, Université René Descartes, 82 Avenue Denfert-Rochereau, F-75674, Paris Cedex, France

    Olivier Dulac

Authors
  1. N. Sarisjulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olivier Dulac
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, Toxicology, and Pharmacy, School of Veterinary Medicine, Bünteweg 17, Bldg. 225, D-30559, Hannover, Germany

    Wolfgang Löscher

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this chapter

Cite this chapter

Sarisjulis, N., Dulac, O. (1999). Valproate in the treatment of epilepsies in children. In: Löscher, W. (eds) Valproate. Milestones in Drug Therapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8759-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8759-5_6

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9761-7

  • Online ISBN: 978-3-0348-8759-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation